The world needs greater transparency on the pricing of medicines – and an overhaul of some approaches – in order to increase access to life-saving drugs, global health experts said.

If “some” data helps life sciences firms develop insights to improve their businesses, having access to Big Data from multiple sources should lead to many more and much better insights. But more often than not, access to more data is having the opposite effect.

To reach payer audiences, companies have to focus far less on promotional tactics and show the value of their products.